(1S*,3R*,7R*,9S*,10S*,14R*)-10-HYDROXY-7-METHYL-3-PENTYL-2,8,13-TRIOXATRICYCLO-[8.5.0.0(9,14)]-PENTADECANE-12-ONE
Compound with spectra: 1 NMR
![(1S*,3R*,7R*,9S*,10S*,14R*)-10-HYDROXY-7-METHYL-3-PENTYL-2,8,13-TRIOXATRICYCLO-[8.5.0.0(9,14)]-PENTADECANE-12-ONE](/api/compound/5yaAp4sIcn4.png?ph=true&h=300&w=458 "(1S*,3R*,7R*,9S*,10S*,14R*)-10-HYDROXY-7-METHYL-3-PENTYL-2,8,13-TRIOXATRICYCLO-[8.5.0.0(9,14)]-PENTADECANE-12-ONE")
| SpectraBase Compound ID | 5yaAp4sIcn4 |
|---|---|
| InChI | InChI=1S/C18H30O5/c1-3-4-5-7-12-8-6-9-18(2)15(21-12)11-14-17(23-18)13(19)10-16(20)22-14/h12-15,17,19H,3-11H2,1-2H3/t12-,13+,14-,15+,17+,18-/m1/s1 |
| InChIKey | JVTGKILQBIUADU-IFWMIRRMSA-N |
| Mol Weight | 326.43 g/mol |
| Molecular Formula | C18H30O5 |
| Exact Mass | 326.209324 g/mol |
| Enantiomer InChIKey | JVTGKILQBIUADU-CSPNZSTDSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
(1S*,3R*,7R*,9S*,10S*,12R*,14R*)-10-HYDROXY-12-HYDROXYALLYLMETHYL-7-METHYL-3-PENTYL-2,8,13-TRIOXATRICYCLO-[8.5.0.0(9,14)]-PENTADECANE
D-Gluco-Octitol, 3,7-anhydro-1,4-dideoxy-2-C-methyl-, 5,6,8-triacetate 2-(3,5-dinitrobenzoate)
(2R*,3S*,5S*,6S*)-5-BENZYLOXY-2,3-DIACETOXY-1,7-DIOXASPIRO-[5.5]-UNDECANE
(2R,4aR,5aS,7R,8S,9aR,11aS)-2,9a-dimethyl-8-vinyldecahydro-[1,3]dioxino[5,4-b]pyrano[2,3-f]oxepin-7-ol
4,5-DI-O-CAFFEOYL-1,3-DI-O-COUMAROYL-QUINIC_ACID
BOTCINIC_ACID
7,8-secoeupalmerin-15-carboxylic acid methyl ester
FJDXMYNEHWZSGG-WUXXAJNRSA-N
(2R,3R,3aS,7R,7aS)-3-benzoxy-7-hydroxy-2-phenyl-2,3,3a,6,7,7a-hexahydrofuro[3,2-b]pyran-5-one
(-)-(1S,5S,6S,8R,9R)-9-(Benzyloxy)-5-hydroxy-8-phenyl-2,7-dioxabicyclo[4.3.0]nonan-3-one [goniofupyrone(6)]
| Title | Journal or Book | Year |
|---|---|---|
| Development of an Approach to the Synthesis of the ABC Ring System of Hemibrevetoxin B | Organic Letters | 2006 |